Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Pfizer. Pfizer Inc. (NYSE: PFE) announced the sale of approximately 618 million ordinary shares in...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Pfizer. Pfizer Inc. (NYSE: PFE) announced the sale of 700 million ordinary shares in Haleon...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Pfizer. On October 1, 2024, Pfizer Inc. (NYSE: PFE) announced the sale of 640 million...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as legal advisor to Pfizer on the transaction. Haleon plc (LSE/NYSE: HLN) announced that Pfizer Inc. (NYSE: PFE) intends to...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin is advising Pfizer and Amplyx Pharmaceuticals on this transaction. Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into an asset purchase agreement with Amplyx Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer on the deal. Pfizer announced a strategic collaboration with Flagship Pioneering to create a new pipeline of innovative medicines. The collaboration...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer on the deal. Pfizer announced its strategic investment in and collaboration with CellCentric, which includes $25 million to help finance further development...
You must be a Standard 1 Year member to access this content.
Skadden and Drew & Napier advised Pfizer Inc. on the offering, while Simpson Thacher & Bartlett and Linklaters Singapore advised the underwriters. Pfizer Inc. (“Pfizer”) announced...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz is acting as Pfizer’s legal advisor. Sullivan & Cromwell is serving as Seagen’s Board of Directors legal advisor. Skadden is advising...
You must be a Standard 1 Year member to access this content.
Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer. Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented Pfizer, while Cravath, Swaine & Moore and Goodwin Procter represented Global Blood Therapeutics in the transaction. Latham & Watkins represented the...
You must be a Standard 1 Year member to access this content.
